Interactive Pharma Solutions (IPS) and Sana Labs are joining forces to deliver a suite of fully compliant AI-powered platforms for the pharmaceutical and global health sectors
October 2, 2020, Oxford & Stockholm
The powerful combination of IPS’ science and technology expertise, and an AI-powered platform from Sana Labs, will transform medical education and health literacy, and drive better patient outcomes.
“By bringing together our expert knowledge of digital healthcare, pharmaceuticals and global health, with Sana Labs’ expertise in the development and application of AI, we aim to establish a new level of digital innovation in the organisations we work with and for the people and patients they support” says Peter Ward CEO, IPS.
“Medical education is more important now than ever before. Together with IPS, we combine the next generation of AI-powered personalized learning with the best in digital healthcare to advance the field and ultimately improve patient outcomes” says Sana Labs CEO, Joel Hellermark.
About Interactive Pharma Solutions
IPS is an Oxford-based Science, Compliance, and Technology company, developing innovative digital solutions for the pharmaceutical and global health sectors. Specialising in building digital communities, patient support, education, and training platforms and working with 10 of the top 20 pharmaceutical companies as well as several of the world’s leading philanthropic foundations and scientific organisations.
Learn more at interactivepharma.com
About Sana Labs
Sana Labs is the global leader in AI for learning. The company provides a personalized, adaptive learning platform used by Fortune 500 companies for workforce training, upskilling and reskilling. The team is made up of world-leading engineers and researchers with backgrounds ranging from Google AI and BCG Gamma to Harvard and Spotify. The company is headquartered in Stockholm, Sweden.
Learn more at sanalabs.com